Eli Lilly's Zepbound Weight Loss Drug No Longer in Shortage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
LILLY DRN
Ro to Offer Zepbound Vials of Weight Loss Drug Working with Eli Lilly
Patients will be able to access Zepbound single-dose vials in Ro Courtesy: Ro Direct-to-consumer healthcare startup Ro said Wednesday that…
The agreement with Novo Nordisk Catalent is closer to closing
A view of the Novo Nordisk logo at the company's office in Bagsvaerd, outside Copenhagen, Denmark, on March 8, 2024.…
Eli Lilly Zepbound causes more weight loss than Novo Nordisk Wegovy: trial
A merged image shows an injectable pen of Zepbound, Eli Lilly's weight-loss drug, and boxes of Wegovy, made by Novo…
Orders for Zepbound and Wegovy weight loss drugs double: GoodRx
A merged image shows an injectable pen of Zepbound, Eli Lilly's weight-loss drug, and boxes of Wegovy, made by Novo…
Wall Street mulls data on weight-loss drug Amgen
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Eli Lilly's obesity drug beats rival in head-to-head trial, where Cramer thinks stock will be next
The new trial data has cemented Club's lead position behind Eli Lilly in the highly competitive anti-obesity drug race. Eli…
Amgen says anti-obesity drug MariTide caused up to 20% weight loss after one year
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Eli Lilly's cholesterol pill impresses in trial
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
2 health stocks are buys. They're pretty disappointed with Trump RFK Jr.'s pick for HHS
We are purchasing 25 shares of Danaher at approximately $229 each. Following Monday's trade, Jim Cramer's Charitable Trust will own…